| Pharmaceutical active ingredients: |
| Dihydroergotamine Mesylate |
| Available forms, composition and doses of Clavigrenin: |
| N / A |
| Clavigrenin medical category: |
| Human:Antimigraine preparationsSympatholytic (adrenergic blocking) agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N02CA01 - Dihydroergotamine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| IVAXHormosan Pharma |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Clavepen | Amoxicillin Trihydrate; Clavulanic Acid (Clavulanate Potassium) | GlaxoSmithKline; Almirall; Labesfal |
| Claver | Amoxicillin; Clavulanic Acid | Zenon Healthcare |
| Claversal | Mesalamine | GlaxoSmithKline; Altana Pharma; Faes Farma; Merck; Merckle; Tramedico |
| Clavicef | Cefixime; Clavulanic Acid (Clavulanate Potassium) | Cadila |
| Clavid-A | Amoxicillin; Amoxicillin Trihydrate; Clavulanic Acid | Invision Medi Sciences |
| Clavigrenin Akut | Ergotamine Tartrate | Hormosan Pharma |
| Clav-II | Amoxicillin; Clavulanic Acid | Biosync Pharmaceuticals |
| Clav-II-Duo | Amoxicillin; Clavulanic Acid | Biosync Pharmaceuticals |
| Clavimox | Amoxicillin; Clavulanic Acid | Lark Laboratories; International Apex Pharmaceuticals; Swiss Parenterals |
| Clavinex | Amoxicillin; Clavulanic Acid (Clavulanate Potassium) | Saval Laboratorios |